BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6152260)

  • 1. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
    Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
    Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of ovarian function using first morning urine steroid assays.
    Denari JH; Farinati Z; Casas PR; Oliva A
    Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
    Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
    J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
    Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity.
    Rapi S; Fuzzi B; Mannelli M; Pratesi S; Criscuoli L; Pellegrini S; Messeri G
    Acta Eur Fertil; 1992; 23(2):63-8. PubMed ID: 1338258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
    Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
    Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
    Adekunle AO; Collins WP; Whitehead MI
    Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enzymatic determination of urinary estrone and estradiol: correlations with plasma estradiol in the menstrual cycle in women].
    Nicolas JC; Chikhaoui Y; Bressot N; Bornadet A; Descomps B; Cristol P; Hedon B
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(4):477-81. PubMed ID: 7142668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of ovulation with the assessment of LH and the E1G/P2G ratio in urinary samples.
    Baviera G; Carroccio G; Scurria L; Pizzi V; Scarselli G
    Acta Eur Fertil; 1988; 19(3):139-42. PubMed ID: 3067480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
    Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
    J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites.
    Baird DD; McConnaughey DR; Weinberg CR; Musey PI; Collins DC; Kesner JS; Knecht EA; Wilcox AJ
    Epidemiology; 1995 Sep; 6(5):547-50. PubMed ID: 8562634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of monitoring menstrual function in field studies: efficacy of methods.
    Kesner JS; Wright DM; Schrader SM; Chin NW; Krieg EF
    Reprod Toxicol; 1992; 6(5):385-400. PubMed ID: 1463919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
    Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
    Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personal hormone monitoring for contraception.
    Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
    Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.